These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


383 related items for PubMed ID: 17039451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD, Ellsworth MA, Tucker CM, Cortese VS.
    J Am Vet Med Assoc; 2006 May 15; 228(10):1559-64. PubMed ID: 16677126
    [Abstract] [Full Text] [Related]

  • 3. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS, Grooms DL, Ellis J, Bolin SR, Ridpath JF, Brock KV.
    Am J Vet Res; 1998 Nov 15; 59(11):1409-13. PubMed ID: 9829398
    [Abstract] [Full Text] [Related]

  • 4. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
    Ellsworth MA, Fairbanks KK, Behan S, Jackson JA, Goodyear M, Oien NL, Meinert TR, Leyh RD.
    Vet Ther; 2006 Nov 15; 7(3):295-304. PubMed ID: 17039452
    [Abstract] [Full Text] [Related]

  • 5. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
    Kelling CL, Hunsaker BD, Steffen DJ, Topliff CL, Eskridge KM.
    Am J Vet Res; 2007 Jul 15; 68(7):788-96. PubMed ID: 17605616
    [Abstract] [Full Text] [Related]

  • 6. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV, McCarty K, Chase CC, Harland R.
    Vet Ther; 2006 Jul 15; 7(1):27-34. PubMed ID: 16598681
    [Abstract] [Full Text] [Related]

  • 7. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W, Mattick D, Smith L.
    Vaccine; 2011 Jun 24; 29(29-30):4657-62. PubMed ID: 21596076
    [Abstract] [Full Text] [Related]

  • 8. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b.
    Leyh RD, Fulton RW, Stegner JE, Goodyear MD, Witte SB, Taylor LP, Johnson BJ, Step DL, Ridpath JF, Holland BP.
    Am J Vet Res; 2011 Mar 24; 72(3):367-75. PubMed ID: 21355740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
    Grooms DL, Bolin SR, Coe PH, Borges RJ, Coutu CE.
    Am J Vet Res; 2007 Dec 24; 68(12):1417-22. PubMed ID: 18052749
    [Abstract] [Full Text] [Related]

  • 11. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
    Kovács F, Magyar T, Rinehart C, Elbers K, Schlesinger K, Ohnesorge WC.
    Vet Microbiol; 2003 Oct 17; 96(2):117-31. PubMed ID: 14519330
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of fetal protection against experimental infection with type 1 and type 2 bovine viral diarrhea virus after vaccination of the dam with a bivalent modified-live virus vaccine.
    Fairbanks KK, Rinehart CL, Ohnesorge WC, Loughin MM, Chase CC.
    J Am Vet Med Assoc; 2004 Dec 15; 225(12):1898-904. PubMed ID: 15643841
    [Abstract] [Full Text] [Related]

  • 13. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
    Givens MD, Marley MS, Jones CA, Ensley DT, Galik PK, Zhang Y, Riddell KP, Joiner KS, Brodersen BW, Rodning SP.
    J Am Vet Med Assoc; 2012 Aug 15; 241(4):484-95. PubMed ID: 22852575
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH, Givens MD, Rodning SP, Riddell KP, Brodersen BW, Scruggs D, Short T, Grotelueschen D.
    Vaccine; 2017 Feb 15; 35(7):1046-1054. PubMed ID: 28111144
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a modified live virus type-1a bovine viral diarrhea virus vaccine (Singer strain) against a type-2 (strain 890) challenge.
    Fairbanks K, Schnackel J, Chase CC.
    Vet Ther; 2003 Feb 15; 4(1):24-34. PubMed ID: 12756633
    [Abstract] [Full Text] [Related]

  • 16. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
    Antonis AF, van Oirschot JT, van Es M, Bruschke CJ.
    Tijdschr Diergeneeskd; 2001 Mar 15; 126(6):208-11. PubMed ID: 11285641
    [Abstract] [Full Text] [Related]

  • 17. Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine.
    Xue W, Mattick D, Smith L, Maxwell J.
    Can J Vet Res; 2009 Oct 15; 73(4):292-7. PubMed ID: 20046631
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with a modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains.
    Xue W, Mattick D, Smith L, Umbaugh J, Trigo E.
    Vaccine; 2010 Dec 10; 29(1):70-6. PubMed ID: 21034829
    [Abstract] [Full Text] [Related]

  • 19. [Kinetics and persistence of neutralizing antibodies against bovine viral diarrhea virus-1 and -2 and border disease virus after two step vaccination of cattle].
    Oguzoglu TC, Frey HR, Eicken K, Grummer B, Liess B, Moennig V.
    Dtsch Tierarztl Wochenschr; 2003 Jan 10; 110(1):14-7. PubMed ID: 12596665
    [Abstract] [Full Text] [Related]

  • 20. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W, Ellis J, Mattick D, Smith L, Brady R, Trigo E.
    Vaccine; 2010 May 14; 28(22):3784-92. PubMed ID: 20381643
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.